₩52,800.00+66.82% · 3M
Moving avg
1W+18.65%
1M+30.86%
3M+66.82%
6M+34.01%
YTD+44.66%
1Y+32.00%
3Y+63.21%
5Y-27.24%
52-week range
$19.0285% of range$42.72
Company health
Value2/6
Growth5/6
Profitability3/6
Health3/6
Dividend4/6
Bull vs bear
Strengths
- High return on equity (1527%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$2.66B
Enterprise value
$2.47B
P/E ratio (TTM)
21.84x
P/S ratio (TTM)
2.30x
EV/EBITDA
34.32x
Per share & returns
EPS (TTM)
$1.64
Dividend yield
0.63%
Beta (1Y)
0.45
30-day change
+30.86%
Trading
Volume (24h)
324.17K
Previous close
₩51,500.00
Shares outstanding
67.71M
About Hanmi Science Co., Ltd.
Sector
Healthcare
Industry
Medical - Distribution
Exchange
KRX
Symbol
008930.KS
Hanmi Science Co., Ltd. is a mid-cap healthcare company in the Medical - Distribution industry.
Frequently asked questions
What is Hanmi Science Co., Ltd.'s market cap?
Hanmi Science Co., Ltd. (008930.KS) has a market capitalization of $2.66B.
What is Hanmi Science Co., Ltd.'s P/E ratio?
Hanmi Science Co., Ltd. trades at a price-to-earnings (P/E) ratio of 21.84.
What exchange does 008930.KS trade on?
008930.KS trades on KRX.
Appears in
Eli Lilly and CompanyLLY
$1,148.20-0.98%
$1.08T cap
Johnson & JohnsonJNJ
$275.23-1.15%
$663.28B cap
AbbVie Inc.ABBV
$256.34-1.49%
$452.90B cap
Merck & Co., Inc.MRK
$150.34-1.31%
$371.31B cap
UnitedHealth Group IncorporatedUNH
$397.14-0.95%
$360.66B cap
Roche Holding AGSWX: ROP
CHF 357.00+0.14%
$350.91B cap
Novartis AGSWX: NOVN
CHF 129.58-1.33%
$304.13B cap
AstraZeneca PLCLON: AZN
£120.06-1.15%
$251.66B cap